Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery
- 26 April 2002
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 774 (2) , 127-140
- https://doi.org/10.1016/s1570-0232(02)00169-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Nelfinavir Plasma Levels Under Twice-Daily and Three-Times-Daily Regimens: High Interpatient and Low Intrapatient VariabilityTherapeutic Drug Monitoring, 2001
- High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individualsAIDS, 2001
- Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patientsAIDS, 2001
- LopinavirDrugs, 2000
- Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- HPLC-UV method for the quantitation of nevirapine in biological matrices following solid phase extraction.Journal of Pharmaceutical and Biomedical Analysis, 1999
- Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- The pharmacokinetics of combination therapy with nelfinavir plus nevirapineAIDS, 1998
- Pharmacokinetics of nevirapine: initial single-rising-dose study in humansAntimicrobial Agents and Chemotherapy, 1993